Bruno Reversade
Impact in
- Pharmacology top 1%
- Apelin-related biomedical research
- Molecular Biology top 2%
- Developmental Biology and Gene Regulation
- Connective Tissue Growth Factor Research
- TGF-β signaling in diseases
- Congenital heart defects research
- Inflammasome and immune disorders
Papers in
- Genetics 26
- Genomic variations and chromosomal abnormalities 8
- Co-authors
- Edward M. De RobertisJosé G. AbreuLena HoSerene C. ChngJing TianHiroki KurodaHojoon LeeMichael Oelgeschläger
- Journals
- Development (6 papers)eLife (6 papers)Developmental Cell (4 papers)Nature Communications (3 papers)Biochemistry and Cell Biology (2 papers)
- Partner nations
- SingaporeUnited StatesTürkiye
In The Last Decade
Bruno Reversade
86 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Pharmacology 876
- Molecular Biology 3.0k
- Cellular and Molecular Neuroscience 664
- Cell Biology 394
- Surgery 965
Countries citing papers authored by Bruno Reversade
This map shows the geographic impact of Bruno Reversade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Reversade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Reversade more than expected).
Fields of papers citing papers by Bruno Reversade
This network shows the impact of papers produced by Bruno Reversade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Reversade. The network helps show where Bruno Reversade may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bruno Reversade, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 6 | |
| 6 | 2022 | 7 | |
| 7 | 2021 | 42 | |
| 8 | 2020 | 3 | |
| 9 | 2020 | 16 | |
| 10 | 2020 | 35 | |
| 11 | 2019 | 2 | |
| 12 | 2018 | 44 | |
| 13 | 2018 | 165 | |
| 14 | 2017 | 15 | |
| 15 | 2017 | 168 | |
| 16 | 2017 | 1 | |
| 17 | 2013 | 19 | |
| 18 | 2012 | 18 | |
| 19 | 2006 | 175 | |
| 20 | 2005 | 120 |
About Bruno Reversade
Bruno Reversade is a scholar working on Developmental Biology, Genetics, Molecular Biology, Pharmacology and Cell Biology, having authored 87 papers that have together received 4.4k indexed citations. Recurring topics across this work include Apelin-related biomedical research (12 papers), Developmental Biology and Gene Regulation (10 papers), Congenital heart defects research (9 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (8 papers), Renal and related cancers (8 papers), Genomic variations and chromosomal abnormalities (8 papers), Nuclear Receptors and Signaling (8 papers) and Pluripotent Stem Cells Research (7 papers). The work is most often cited by research in Pharmacology (876 citations), Molecular Biology (3.0k citations), Cellular and Molecular Neuroscience (664 citations), Cell Biology (394 citations) and Surgery (965 citations). Bruno Reversade has collaborated with scholars based in Singapore, United States and Türkiye. Frequent co-authors include Edward M. De Robertis, José G. Abreu, Lena Ho, Serene C. Chng, Jing Tian, Hiroki Kuroda, Hojoon Lee, Michael Oelgeschläger, Andrea L. Ambrosio and Lise Zakin. Their work appears in journals such as Development, eLife, Developmental Cell, Nature Communications and Biochemistry and Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.